The PE Ratio as of September 2024 (TTM) for Crinetics Pharmaceuticals, Inc. (CRNX) is -13.40

According to Crinetics Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -13.40. This represents a change of 27.19% compared to the average of -10.54 of the last 4 quarters.

Crinetics Pharmaceuticals, Inc. (CRNX) Historical PE Ratio (quarterly & annually)

How has CRNX PE Ratio performed in the past?

The mean historical PE Ratio of Crinetics Pharmaceuticals, Inc. over the last ten years is -18.88. The current -13.40 PE Ratio has changed 7.00% with respect to the historical average. Over the past ten years (40 quarters), CRNX's PE Ratio was at its highest in in the June 2023 quarter at -4.80. The PE Ratio was at its lowest in in the June 2017 quarter at -51.60.

Crinetics Pharmaceuticals, Inc. (CRNX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Crinetics Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Crinetics Pharmaceuticals, Inc. (CRNX) Average PE Ratio

How has CRNX PE Ratio performed in the past?

The current PE Ratio of Crinetics Pharmaceuticals, Inc. (CRNX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Crinetics Pharmaceuticals, Inc. (CRNX) PE Ratio vs. Peers

How is CRNX’s PE Ratio compared to its peers?

Crinetics Pharmaceuticals, Inc.’s PE Ratio is less than Viridian Therapeutics, Inc. (-3.95), less than Cytokinetics, Incorporated (-10.84), greater than Structure Therapeutics Inc. (-18.15), less than Icosavax, Inc. (-8.27), less than Passage Bio, Inc. (0), less than REGENXBIO Inc. (-0.57), less than LianBio (-2.41), less than Kezar Life Sciences, Inc. (-0.39), less than Inhibrx, Inc. (-0.41), less than Merus N.V. (0.13), greater than Lyell Immunopharma, Inc. (-18.45), less than Kronos Bio, Inc. (-1.42), less than Black Diamond Therapeutics, Inc. (-0.58), less than TCR2 Therapeutics Inc. (-3.70), less than Harpoon Therapeutics, Inc. (-0.44), less than Alector, Inc. (-2.94), less than null (-2.92),

Build a custom stock screener for Crinetics Pharmaceuticals, Inc. (CRNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crinetics Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Crinetics Pharmaceuticals, Inc. (CRNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Crinetics Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.